| Dr Amber Christine Robbins, MD | |
|
206 N Brooks St, Sheridan, WY 82801-3801 | |
| (307) 672-8941 | |
| (307) 672-7461 |
| Full Name | Dr Amber Christine Robbins |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 206 N Brooks St, Sheridan, Wyoming |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770670325 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 7697A (Wyoming) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sheridan Memorial Hospital | Sheridan, WY | Hospital |
| Johnson County Healthcare Center | Buffalo, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Robbins Dermatology, P.c. | 0244301844 | 3 |
News Archive
To address the pressing issue of diminishing immunity among older adults to COVID-19 as well to vaccines designed to protect against the virus, a $4.9 million award from the U.S. Centers for Disease Control and Prevention will fund a two-year project led by Brown University researchers and conducted by a team spanning multiple institutions.
We now know that lawmakers who promised that "if you like your plan, you can keep your plan" were wrong. The president likes to say Americans aren't interested in revisiting the debates of the past. No one would accept an answer like that from an electronics store manager who refused to offer a refund on a defective television.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has determined that additional time is required to complete the review of the biologics license application (BLA) for ipilimumab in pre-treated advanced melanoma, and has moved its decision date from December 25, 2010 to March 26, 2011.
"Vaccine program workers, who sometimes struggle to gain public trust and governmental cooperation in the first place, are furious about the deception" of the CIA in establishing a fake vaccination program in Pakistan in an attempt to gather DNA from Osama bin Laden's family, ScienceInsider reports.
Cryopraxis/CellPraxis aims to start patient recruitment for its Phase III Refractory Angina Cell Therapy Brazilian arm clinical trial by the end of 2012 or early 2013.
› Verified 6 days ago
| Entity Name | Robbins Dermatology, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982870697 PECOS PAC ID: 0244301844 Enrollment ID: O20080625000002 |
News Archive
To address the pressing issue of diminishing immunity among older adults to COVID-19 as well to vaccines designed to protect against the virus, a $4.9 million award from the U.S. Centers for Disease Control and Prevention will fund a two-year project led by Brown University researchers and conducted by a team spanning multiple institutions.
We now know that lawmakers who promised that "if you like your plan, you can keep your plan" were wrong. The president likes to say Americans aren't interested in revisiting the debates of the past. No one would accept an answer like that from an electronics store manager who refused to offer a refund on a defective television.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has determined that additional time is required to complete the review of the biologics license application (BLA) for ipilimumab in pre-treated advanced melanoma, and has moved its decision date from December 25, 2010 to March 26, 2011.
"Vaccine program workers, who sometimes struggle to gain public trust and governmental cooperation in the first place, are furious about the deception" of the CIA in establishing a fake vaccination program in Pakistan in an attempt to gather DNA from Osama bin Laden's family, ScienceInsider reports.
Cryopraxis/CellPraxis aims to start patient recruitment for its Phase III Refractory Angina Cell Therapy Brazilian arm clinical trial by the end of 2012 or early 2013.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amber Christine Robbins, MD 206 N Brooks St, Sheridan, WY 82801-3801 Ph: (307) 672-8941 | Dr Amber Christine Robbins, MD 206 N Brooks St, Sheridan, WY 82801-3801 Ph: (307) 672-8941 |
News Archive
To address the pressing issue of diminishing immunity among older adults to COVID-19 as well to vaccines designed to protect against the virus, a $4.9 million award from the U.S. Centers for Disease Control and Prevention will fund a two-year project led by Brown University researchers and conducted by a team spanning multiple institutions.
We now know that lawmakers who promised that "if you like your plan, you can keep your plan" were wrong. The president likes to say Americans aren't interested in revisiting the debates of the past. No one would accept an answer like that from an electronics store manager who refused to offer a refund on a defective television.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has determined that additional time is required to complete the review of the biologics license application (BLA) for ipilimumab in pre-treated advanced melanoma, and has moved its decision date from December 25, 2010 to March 26, 2011.
"Vaccine program workers, who sometimes struggle to gain public trust and governmental cooperation in the first place, are furious about the deception" of the CIA in establishing a fake vaccination program in Pakistan in an attempt to gather DNA from Osama bin Laden's family, ScienceInsider reports.
Cryopraxis/CellPraxis aims to start patient recruitment for its Phase III Refractory Angina Cell Therapy Brazilian arm clinical trial by the end of 2012 or early 2013.
› Verified 6 days ago